Long-Term Survival in Patients With Advanced Melanoma.

Autor: van Not OJ; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Jalving H; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Haanen JB; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center Sittard, Sittard-Geleen, the Netherlands., Blank CU; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., de Groot J W B JW; Isala Oncology Center, Isala, Zwolle, the Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Leeneman B; Department of Health Technology Assessment, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.; Erasmus Center for Health Economics Rotterdam, Erasmus University Rotterdam, Rotterdam, the Netherlands., D P; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands., Stevense-den Boer M; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., van der Veldt AAM; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands., Vreugdenhil G G; Department of Internal Medicine, Maxima Medical Center, Eindhoven, the Netherlands., Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Blokx WAM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Publikováno v: JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2426641. Date of Electronic Publication: 2024 Aug 01.

The Role of Recombinant Human Erythropoietin in the Treatment of Thalassemia.

Autor: RACHMILEWITZ, ELIEZER A., AKER, MEMET

Publikováno v: Annals of the New York Academy of Sciences; 1998, Vol. 850 Issue 1, p129-138, 10p